Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $4,331,581.01 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 278,917 shares of the stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.53, for a total value of $4,331,581.01. Following the transaction, the president now directly owns 2,303,975 shares of the company’s stock, valued at approximately $35,780,731.75. This trade represents a 10.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Price Performance

NASDAQ:ALHC opened at $14.89 on Friday. The firm has a market capitalization of $2.86 billion, a price-to-earnings ratio of -19.34 and a beta of 1.49. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $16.25. The stock has a fifty day moving average of $13.97 and a 200 day moving average of $12.21. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Institutional Investors Weigh In On Alignment Healthcare

Large investors have recently added to or reduced their stakes in the business. R Squared Ltd purchased a new stake in Alignment Healthcare during the fourth quarter valued at about $55,000. RiverPark Advisors LLC purchased a new stake in Alignment Healthcare during the fourth quarter valued at about $106,000. Tower Research Capital LLC TRC raised its position in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after purchasing an additional 6,286 shares in the last quarter. Ballentine Partners LLC purchased a new stake in Alignment Healthcare during the fourth quarter valued at about $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Alignment Healthcare during the third quarter valued at about $131,000. Institutional investors own 86.19% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Piper Sandler increased their price objective on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, March 4th. Bank of America raised their price target on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a report on Tuesday, March 4th. Barclays raised their price target on Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a report on Friday, February 28th. Stifel Nicolaus raised their price target on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Finally, JPMorgan Chase & Co. raised their price target on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $14.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.